HQH (HQH)

Abrdn Healthcare Investors (NYSE:HQH) is scheduled to go ex-dividend on August 24th, 2026. Shareholders recorded on or before the record date will receive a dividend of 0.66 USD per share. This information is crucial for investors tracking dividend payouts.

This article provides the "Price to sales forward" metric for abrdn Healthcare Investors Shares of Beneficial Interest (NYSE: HQH). It includes standard financial data and company identification within the TradingView platform context. The content is primarily a listing of financial and market information rather than an analytical piece.

This article lists several ETFs that invest in abrdn Healthcare Investors of Benef Interest (HQH) stocks. It provides key financial data for each ETF, including market value, weight, issuer, management style, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV total return. The ETFs highlighted are Amplify CEF High Income ETF, First Trust Income Opportunities ETF, and Saba Closed-End Funds ETF.

Director Chris Mahai recently purchased 501 shares of abrdn Healthcare Investors (HQH) on July 16, 2026, marking his total ownership at 501 shares. The closed-end fund, which invests in healthcare companies, was trading at $20.96 per share with a market cap of $1,201.037 million at the time of purchase. According to GuruFocus, HQH has a price-to-GF-Value ratio of 0.42, suggesting it could be a "Possible Value Trap."

abrdn Healthcare Investors director Mahai Chris LaVictoire purchased 501 shares of the company's common stock at $20.96 per share, totaling $10,500.96. Following this transaction, LaVictoire directly owns 501 shares. This information was generated by Public Technologies (PUBT) using AI based on content published by abrdn Healthcare Investors via EDGAR.